NewsNovo

Silo Pharma pays 165,000 shares for software assets sold by its own crypto advisor

8/20/2026

The acquisition is stock-for-IP, and the terms are clean enough on paper. The seller is not an arm's-length party.

Parkview Consulting LLC agreed on August 18, 2026 to transfer certain software, technology, domain names, and related intellectual property to Silo Pharma, Inc.

Parkview's sole member and manager, Corwin Yu, simultaneously holds the title of lead strategic advisor on Silo's Cryptocurrency Advisory Board.

The company issued 165,000 shares of common stock, par value $0.0001 per share, to Parkview as the entire consideration.